Trial Profile
Treatment of Active Anterior Uveitis Associated With JIA, Using Humanized Anti-Tac (HAT, Daclizumab)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 May 2019
Price :
$35
*
At a glance
- Drugs Daclizumab (Primary)
- Indications Anterior uveitis
- Focus Adverse reactions; Therapeutic Use
- 12 Apr 2014 New trial record
- 21 May 2008